共 36 条
- [21] A novel transcription factor Rwdd1 and its SUMOylation inhibit the expression of sqr, a key gene of mitochondrial sulfide metabolism in Urechis unicinctusAQUATIC TOXICOLOGY, 2018, 204 : 180 - 189Li, XueyuLiu, XiaolongQin, ZhenkuiWei, MaokaiHou, XitanZhang, TingtingZhang, Zhifeng
- [22] Discovery of Novel Pyrrolo[2,3-d]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid TumorsJOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (02) : 1243 - 1264Liang, XuewuTang, ShuaiLiu, XuyiLiu, YingluoXu, QifuWang, XiaominSaidahmatov, AbdusaidLi, ChunpuWang, JiangZhou, YuZhang, YingjieGeng, MeiyuHuang, MinLiu, Hong
- [23] A first-in-human phase 1 study of GC1118, a novel monoclonal antibody inhibiting epidermal growth factor receptor (EGFR), in patients with advanced solid tumors.JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Lee, Keun WookOh, Do-YounHan, Sae-WonKim, Jin WonShin, Jung-WonJo, Seong-JinKim, Na HyungWoo, AhmiWon, JonghwaHahn, SeokyungLee, HowardKim, Woo HoBang, Yung-Jue
- [24] Discovery of Novel 2-Aminopyridine-Based and 2-Aminopyrimidine-Based Derivatives as Potent CDK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors and Hematological MalignanciesJOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (17) : 15220 - 15245Saidahmatov, AbdusaidLi, JiananXu, ShihaoHu, XiaobeiGao, XiangqianKan, WeijuanGao, LixinLi, CongShi, YuqiangSheng, LiWang, PeipeiZhou, YuboLiang, XuewuLi, JiaLiu, Hong
- [25] Dose-escalation of the first-in human phase I/Ib study of ABTL0812, a novel antitumor drug inhibiting the Akt/mTOR pathway in patients with advanced solid tumors.JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Vidal Boixader, LauraGaba, LydiaVictoria, IvanBrunet, MerceParedes, PilarBuxo, ElviraVilella, TeresaRiu, GiselaCortal, MarcGomez-Ferreria, MarianaAlfon, JoseDomenech, CarlesGascon, Pedro
- [26] The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives (vol 119, pg 3321, 2012)BLOOD, 2014, 124 (09) : 1539 - 1539Bernstein, S. H.Venkatesh, S.Li, M.
- [27] EFFECTS OF NOVEL ANTIARRHYTHMIC AGENTS, BRB-I-28 AND ITS DERIVATIVES, ON THE HEART MITOCHONDRIAL RESPIRATORY-CHAIN AND SARCOPLASMIC-RETICULUM CA2+-ATPASERESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1994, 85 (02) : 193 - 208CHEN, CLSANGIAH, SYU, CACHEN, HBERLIN, KDGARRISON, GLSCHERLAG, BJLAZZARA, R
- [28] Discovery of Novel Azaphenothiazine Derivatives to Suppress Endometrial Cancer by Targeting GRP75 to Impair Its Interaction with IP3R and Mitochondrial Ca2+ HomeostasisJOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (16) : 13829 - 13851Ling, XianwuZhang, JiahuiSong, LingyiWu, HuiwenWang, QiLiu, XiaohuNi, WeiLi, JianWang, YudongMao, Fei
- [29] Novel synthetic approach to 19-nor-1α,25-dihydroxyvitamin D3 and its derivatives by Suzuki-Miyaura coupling in solution and on solid supportORGANIC LETTERS, 2001, 3 (24) : 3975 - 3977Hanazawa, TWada, TMasuda, TOkamoto, SSato, F
- [30] MITOPE: Phase 2 evaluation of RSO-021, a novel mitochondrial PRX3 inhibitor, as a monotherapy and in combination with paclitaxel in patients with malignant pleural effusion due to mesothelioma or other advanced solid tumorsEUROPEAN JOURNAL OF CANCER, 2024, 211 : S56 - S56Naumov, G.Dulloo, S.Fennell, D.Lord, S.Thistlethwaite, F.Maskell, N.Popat, S.Blyth, K.Szlosarek, P.Aujayeb, A.Franks, K.Herrero, J.Cunniff, B.Duncan, J.Graham, P.Bexon, A.Spicer, J.